Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Stevanato Group S.p.A. (NYSE:STVN) has earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and two have issued a strong buy recommendation on the company.

A number of brokerages have recently weighed in on STVN. UBS Group began coverage on Stevanato Group in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $23.00 target price for the company. TD Cowen raised Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Finally, Weiss Ratings raised shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th.

Stevanato Group Stock Up 1.1%

NYSE STVN opened at €20.20 on Thursday. The stock’s 50 day moving average is €21.11 and its two-hundred day moving average is €18.46. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €27.99. The company has a market capitalization of $6.12 billion, a price-to-earnings ratio of 36.07, a PEG ratio of 1.65 and a beta of 0.78. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.21.

Stevanato Group (NYSE:STVN) last issued its earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing the consensus estimate of €0.15 by (€0.01). The firm had revenue of €302.00 million during the quarter. Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. Equities analysts forecast that Stevanato Group will post 0.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Stevanato Group news, CFO Marco Dal Lago sold 4,209 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €84,558.81. Following the sale, the chief financial officer directly owned 81,144 shares in the company, valued at approximately €1,630,182.96. This trade represents a 4.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Mauro Stocchi sold 13,649 shares of Stevanato Group stock in a transaction that occurred on Monday, September 28th. The shares were sold at an average price of €21.50, for a total transaction of €293,453.50. Following the completion of the transaction, the insider directly owned 400,000 shares in the company, valued at approximately €8,600,000. The trade was a 3.30% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 21,926 shares of company stock valued at $459,738 in the last three months. Insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Stevanato Group

Several institutional investors have recently added to or reduced their stakes in the stock. Integrated Wealth Concepts LLC acquired a new stake in Stevanato Group in the 2nd quarter valued at approximately $59,000. Fifth Third Bancorp boosted its position in Stevanato Group by 22.6% during the 1st quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after acquiring an additional 773 shares during the last quarter. Hardy Reed LLC bought a new position in shares of Stevanato Group during the 1st quarter worth approximately $147,000. Diversify Wealth Management LLC grew its stake in shares of Stevanato Group by 23.9% during the 1st quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company’s stock worth $252,000 after acquiring an additional 3,543 shares in the last quarter. Finally, First Bank & Trust raised its holdings in shares of Stevanato Group by 3.4% in the second quarter. First Bank & Trust now owns 18,417 shares of the company’s stock valued at $333,000 after purchasing an additional 603 shares during the last quarter.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.